Icahn School of Medicine Mount Sinai Beth Isreal — New York, New York

Icahn School of Medicine Mount Sinai Beth Isreal is a clinical research site located in New York, New York, United States 10003.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Icahn School of Medicine Mount Sinai Beth Isreal has participated in 1 clinical trials.

Therapeutic areas: Ulcerative Colitis.

Sponsors: Celgene.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Icahn School of Medicine Mount Sinai Beth Isreal?

Icahn School of Medicine Mount Sinai Beth Isreal has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Icahn School of Medicine Mount Sinai Beth Isreal conducted?

Icahn School of Medicine Mount Sinai Beth Isreal has 1 clinical trials on record. Their work covers Ulcerative Colitis.

Is Icahn School of Medicine Mount Sinai Beth Isreal accredited by Crixeo Health?

Icahn School of Medicine Mount Sinai Beth Isreal has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Icahn School of Medicine Mount Sinai Beth Isreal?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.